Natural Contaminants in Drinking Water Linked to Autism

A UCLA-led study discovered a link between increased lithium levels in tap water and a higher risk of autism spectrum disorder in the offspring of pregnant women exposed to it. The highest lithium levels were associated with a 46% higher autism risk compared to the lowest levels.

For the first time, researchers report a possible link between autism and lithium in the water supply.

A study led by a

Pregnant women whose household tap water had higher levels of lithium had a moderately higher risk of their offspring being diagnosed with autism spectrum disorder, according to a new study led by a University of California, Los Angeles (UCLA) Health researcher.

The study, published on April 3 in JAMA Pediatrics, is believed to be the first to identify naturally occurring lithium in drinking water as a possible environmental risk factor for autism.

“Any drinking water contaminants that may affect the developing human brain deserve intense scrutiny,” said lead study author Beate Ritz, MD, PhD, professor of neurology in the David Geffen School of Medicine at UCLA and professor of epidemiology and environmental health at the UCLA Fielding School of Public Health. “In the future, anthropogenic sources of lithium in water may become more widespread because of lithium battery use and disposal in landfills with the potential for groundwater contamination. The results of our study are based on high-quality Danish data but need to be replicated in other populations and areas of the world.”

Because of lithium’s mood-stabilizing effects, some lithium compounds have long been used as a treatment for depression and bipolar disorders. However, there has been debate about whether mothers can safely take lithium during pregnancy amid increasing evidence it is associated with higher risk of miscarriage and cardiac anomalies or defects in newborns.

Ritz, whose research focuses on how environmental exposures influence neurodevelopmental disorders and neurodegenerative diseases, said she decided to examine the possible association between lithium and autism risk after finding there had been little research in humans about how lithium affects brain growth and development. Still, she found that some experimental research indicated lithium, which is among several naturally occurring metals often found in water, could affect an important molecular pathway involved in neurodevelopment and autism.

Zeyan Liew, PhD, MPH, first author of the study and an Assistant Professor of Epidemiology at the

As lithium levels increased, so did the risk of an autism diagnosis, the researchers reported. Compared to the lowest quartile of recorded lithium levels – in other words, those in the 25th percentile – lithium levels in the second and third quartiles were associated with a 24-26% higher risk of autism. In the highest quartile, the risk was 46% higher compared to the lowest quartile.

The researchers found a similar relationship between increased lithium levels and higher risk of autism diagnosis when the data were broken down by subtypes of the disorder. They also found the association between lithium levels and autism risk was slightly stronger for those living in urban areas compared to smaller towns and rural areas.

In addition to Denmark’s comprehensive civil databases that have proven to be valuable resources for public health researchers, several other factors made Denmark ideal for this study. Denmark’s consumption of bottled water ranks among the lowest in Europe, meaning Danes largely rely on tap water. The country also has a robust system for measuring trace metals and other contaminants in their water supply. Ritz said lithium levels in Denmark’s water, when compared to other countries, are likely in the low to moderate range.

Reference: “Association Between Estimated Geocoded Residential Maternal Exposure to Lithium in Drinking Water and Risk for Autism Spectrum Disorder in Offspring in Denmark” by Zeyan Liew, PhD, MPH; Qi Meng, MSc; Qi Yan, PhD; Jörg Schullehner, PhD, MSc; Birgitte Hansen, PhD, MSc; Søren Munch Kristiansen, PhD, MSc; Denitza D. Voutchkova, PhD, MSc; Jørn Olsen, MD, PhD; Annette Kjær Ersbøll, PhD; Matthias Ketzel, PhD, MSc; Ole Raaschou-Nielsen, PhD and Beate R. Ritz, MD, PhD, 3 April 2023, JAMA Pediatrics.
DOI: 10.1001/jamapediatrics.2023.0346

Other study authors include Qi Meng and Qi Yan, both of UCLA, and Danish researchers Jörg Schullehner, Birgitte Hansen, Søren Munch Kristiansen, Denitza D. Voutchkova, Jørn Olsen, Annette Kjær Ersbøll, Matthias Ketzel, and Ole Raaschou-Nielsen.

Funding: NIH/National Institute of Environmental Health Sciences, Novo Nordisk Foundation Challenge Program

No Byline Policy

Editorial Guidelines

Corrections Policy

Source